论文信息 - Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma - 字舞流文

Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma

K. Izutsu | K. Tobinai | P. Fustier | H. Nagai | T. Ohtsu | T. Ishikawa | T. Kiguchi | G. Yamamoto | N. Fukuhara | Y. Terui | Y. Minami | T. Jo | Tsutomu Kobayashi | Shuichi Midorikawa | S. Kalambakas